An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications
Introduced
Moved
Reached a final decision
Became law
Derived from the official record below.
Officially: “An Act to Expand Access and Reduce Barriers to Access to Naloxone Hydrochloride and Other Opioid Overdose-reversing Medications” Read the full text
Official title shown verbatim from the official record. Plain-language summary coming as coverage deepens. Not legal advice.
132nd legislature (2025-2026)HP 449
Where it is
Received by the Clerk of the House on February 20, 2025. The Bill was REFERRED to the Committee on HEALTH AND HUMAN SERVICES pursuant to Joint Rule 308.2 and ordered printed pursuant to Joint Rule 401 · Feb 20, 2025
Carried over, in the same posture, to the next special or regular session of the 132nd Legislature, pursuant to Joint Order SP 519.^ · Mar 21, 2025
CONSENT CALENDAR - FIRST DAY Under suspension of the rules CONSENT CALENDAR - SECOND DAY. The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (H-207). Sent for concurrence. ORDER · May 22, 2025
Report READ and ACCEPTED, in concurrence. READ ONCE. Committee Amendment "A" (H-207) READ and ADOPTED, in concurrence. Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS A · May 22, 2025
PASSED TO BE ENACTED. Sent for concurrence. ORDERED SENT FORTHWITH. · May 27, 2025
PASSED TO BE ENACTED, in concurrence. · May 27, 2025
The numbers
1
sponsor on the bill
Sponsors
Samuel Zager
Every fact on this page links to its source, starting with the official bill record. Last action: PASSED TO BE ENACTED, in concurrence. (May 27, 2025).